H T Benzon et al.
British journal of anaesthesia, 111 Suppl 1, i96-113 (2013-12-18)
The new oral anticoagulants are approved for a variety of clinical syndromes, including the prevention of stroke in atrial fibrillation, acute coronary syndromes, treatment of venous thromboembolism (VTE), and prevention of venous thrombosis after total joint surgery or hip fracture.